Afin de réaliser des statistiques de visites et d'améliorer l'expérience utilisateur sur notre site, nous mesurons son audience grâce à une solution utilisant la technologie des cookies.

En naviguant sur ce site, vous acceptez l'utilisation des cookies de mesure d'audience. Pour en savoir plus et paramétrer les cookies



We use cookie technology to measure our online audience in order to compile statistics on website visits and improve the browsing experience for our website's users. 
By using our website, you consent to the use of cookies for audience measurements. Click here for more information on cookies and how to set your preferences

Press releases

Go back

Paris, 12 July 2018

Lagardère announces the disposal of MonDocteur as well as exclusive negotiations for the sale of Doctissimo

As announced by Arnaud Lagardère within the scope of its strategic redeployment, the Group is preparing to sell its e-Health business at an enterprise value of €60 million (based on a 100% equity interest).

MonDocteur, the online medical appointment platform, has been sold to Doctolib, which thereby consolidates its position as the leading e-Health business in Europe.

Doctissimo, a leader in health and wellness information, is subject to exclusive negotiations with the TF1 group aimed at concluding an agreement by 30 September 2018. In accordance with the law, this agreement will be submitted for review by the relevant employee-representative bodies.

Press Contacts

Investor Relations Contact

The Lagardère group is a global leader in content publishing, production, broadcasting and distribution, whose powerful brands leverage its virtual and physical networks to attract and enjoy qualified audiences.
It is structured around four business lines: Books and e-Books; Travel Retail; Press, Audiovisual, Digital and Advertising Sales Brokerage; Sports and Entertainment.

Lagardère shares are listed on Euronext Paris.